Used primarily in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory drugs. It exhibits potential in the development of treatments for autoimmune diseases and certain cancers due to its structural similarity to known cereblon-binding agents. Its application extends to preclinical studies evaluating anti-inflammatory and antiproliferative effects. Commonly employed in structure-activity relationship (SAR) studies to optimize drug candidates targeting protein degradation pathways.